Literature DB >> 23292975

Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models.

Bohdana Ratitch1, Michael O'Kelly, Robert Tosiello.   

Abstract

The need to use rigorous, transparent, clearly interpretable, and scientifically justified methodology for preventing and dealing with missing data in clinical trials has been a focus of much attention from regulators, practitioners, and academicians over the past years. New guidelines and recommendations emphasize the importance of minimizing the amount of missing data and carefully selecting primary analysis methods on the basis of assumptions regarding the missingness mechanism suitable for the study at hand, as well as the need to stress-test the results of the primary analysis under different sets of assumptions through a range of sensitivity analyses. Some methods that could be effectively used for dealing with missing data have not yet gained widespread usage, partly because of their underlying complexity and partly because of lack of relatively easy approaches to their implementation. In this paper, we explore several strategies for missing data on the basis of pattern mixture models that embody clear and realistic clinical assumptions. Pattern mixture models provide a statistically reasonable yet transparent framework for translating clinical assumptions into statistical analyses. Implementation details for some specific strategies are provided in an Appendix (available online as Supporting Information), whereas the general principles of the approach discussed in this paper can be used to implement various other analyses with different sets of assumptions regarding missing data.
Copyright © 2013 John Wiley & Sons, Ltd.

Keywords:  clinical assumptions; missing data; multiple imputation; pattern mixture models; sensitivity analysis

Mesh:

Year:  2013        PMID: 23292975     DOI: 10.1002/pst.1549

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  36 in total

1.  Accounting for not-at-random missingness through imputation stacking.

Authors:  Lauren J Beesley; Jeremy M G Taylor
Journal:  Stat Med       Date:  2021-08-29       Impact factor: 2.373

2.  SMIM: A unified framework of survival sensitivity analysis using multiple imputation and martingale.

Authors:  Shu Yang; Yilong Zhang; Guanghan Frank Liu; Qian Guan
Journal:  Biometrics       Date:  2021-08-27       Impact factor: 2.571

3.  The impact of missing data on clinical trials: a re-analysis of a placebo controlled trial of Hypericum perforatum (St Johns wort) and sertraline in major depressive disorder.

Authors:  Anneke C Grobler; Glenda Matthews; Geert Molenberghs
Journal:  Psychopharmacology (Berl)       Date:  2014-05       Impact factor: 4.530

4.  Healthy Homes/Healthy Kids: a randomized trial of a pediatric primary care-based obesity prevention intervention for at-risk 5-10 year olds.

Authors:  Nancy E Sherwood; Rona L Levy; Shelby L Langer; Meghan M Senso; A Lauren Crain; Marcia G Hayes; Julie D Anderson; Elisabeth M Seburg; Robert W Jeffery
Journal:  Contemp Clin Trials       Date:  2013-06-28       Impact factor: 2.226

5.  Analyzing clinical trial outcomes based on incomplete daily diary reports.

Authors:  Neal Thomas; Ofer Harel; Roderick J A Little
Journal:  Stat Med       Date:  2016-02-16       Impact factor: 2.373

6.  Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial.

Authors:  Tannaz Moin; O Kenrik Duru; Norman Turk; Janet S Chon; Dominick L Frosch; Jacqueline M Martin; Kia Skrine Jeffers; Yelba Castellon-Lopez; Chi-Hong Tseng; Keith Norris; Carol M Mangione
Journal:  J Gen Intern Med       Date:  2019-08-30       Impact factor: 6.473

Review 7.  The rise of multiple imputation: a review of the reporting and implementation of the method in medical research.

Authors:  Panteha Hayati Rezvan; Katherine J Lee; Julie A Simpson
Journal:  BMC Med Res Methodol       Date:  2015-04-07       Impact factor: 4.615

8.  A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials.

Authors:  Rita Faria; Manuel Gomes; David Epstein; Ian R White
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981

9.  Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: additional analyses from the AFFIRM randomized clinical trial.

Authors:  D Cella; C Ivanescu; S Holmstrom; C N Bui; J Spalding; K Fizazi
Journal:  Ann Oncol       Date:  2014-10-30       Impact factor: 32.976

10.  Sachet water consumption as a risk factor for cholera in urban settings: Findings from a case control study in Kinshasa, Democratic Republic of the Congo during the 2017-2018 outbreak.

Authors:  Placide Mbala-Kingebeni; Florian Vogt; Berthe Miwanda; Tresor Sundika; Nancy Mbula; Isaac Pankwa; Leopold Lubula; Veerle Vanlerberghe; Alain Magazani; Mildred Tita Afoumbom; Jean-Jacques Muyembe-Tamfum
Journal:  PLoS Negl Trop Dis       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.